Reply to Kathryn L. Penney, Massimo Loda, and Meir J. Stampfer's Letter to the Editor re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7

被引:0
|
作者
Vickers, Andrew J. [1 ]
Lilja, Hans [2 ,3 ,4 ,5 ,6 ]
Assel, Melissa [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 485 Lexington Ave, New York, NY 10017 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[5] Lund Univ, Dept Translat Med, Malmo, Sweden
[6] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
关键词
D O I
10.1016/j.eururo.2018.10.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E56 / E56
页数:1
相关论文
共 2 条
  • [1] Re: Melissa Assel, Anders Dahlin, David Ulmert, et al. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening. Eur Urol 2018;73:961-7
    Penney, Kathryn L.
    Loda, Massimo
    Stampfer, Meir J.
    EUROPEAN UROLOGY, 2019, 75 (03) : E54 - E55
  • [2] Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening
    Assel, Melissa
    Dahlin, Anders
    Ulmert, David
    Bergh, Anders
    Stattin, Par
    Lilja, Hans
    Vickers, Andrew J.
    EUROPEAN UROLOGY, 2018, 73 (06) : 961 - 967